Sean E. Browne
2023
In 2023, Sean E. Browne earned a total compensation of $1.7M as President and Chief Executive Officer at Xtant Medical Holdings, a 61% increase compared to previous year.
Compensation breakdown
Non-Equity Incentive Plan | $664,560 |
---|---|
Option Awards | $209,266 |
Salary | $600,000 |
Stock Awards | $209,059 |
Other | $29,273 |
Total | $1,712,158 |
Browne received $664.6K in non-equity incentive plan, accounting for 39% of the total pay in 2023.
Browne also received $209.3K in option awards, $600K in salary, $209.1K in stock awards and $29.3K in other compensation.
Rankings
In 2023, Sean E. Browne's compensation ranked 658th out of 3,006 executives tracked by ExecPay. In other words, Browne earned more than 78.1% of executives.
Classification | Ranking | Percentile |
---|---|---|
All | 658 out of 3,006 | 78th |
Division Manufacturing | 366 out of 1,650 | 78th |
Major group Chemicals And Allied Products | 251 out of 918 | 73rd |
Industry group Drugs | 247 out of 881 | 72nd |
Industry Biological Products, Except Diagnostic Substances | 83 out of 213 | 61st |
Source: SEC filing on June 10, 2024.
Browne's colleagues
We found two more compensation records of executives who worked with Sean E. Browne at Xtant Medical Holdings in 2023.
News
Xtant Medical Holdings CEO Sean Browne's 2023 pay jumps 61% to $1.7M
June 10, 2024
Xtant Medical Holdings CEO Sean Browne's 2022 pay jumps 28% to $1.1M
June 7, 2023
Xtant Medical Holdings CFO Greg Jensen's 2021 pay rises 11% to $955K
September 20, 2022
Xtant Medical Holdings CEO Sean Browne's 2020 pay jumps 146% to $4.5M
June 14, 2021